Archive for the ‘Lantis Laser Inc. LLSR’ Category

Lantis Laser (LLSR.OB) Upgrades Their Laser Dentistry Imaging System

Tuesday, June 10th, 2008

Lantis Laser (LLSR.OB) is developing and commercializing advanced technologies for applications in dentistry. The company has exclusive rights to the application of Optical Coherence Tomography (OCT) technology for dental diagnostic imaging through its licensing agreements with LightLab Imaging and Lawrence Livermore National Laboratory. These rights do not expire until 2020.

Lantis Laser announced an agreement a few months ago with Axsun Technologies, leaders in the design of high-performance OCT laser engines. Axsun’s patented swept-source technology enables the highest attainable performance for Optical Coherence Tomography (OCT). Lantis Laser’s proprietary OCT Dental Imaging System is a diagnostic aid that provides real-time, high-resolution chairside imaging of dental tissue for the early detection of tooth decay and other oral diseases, at a resolution of up to 10 times that of an x-ray. Since the imaging system is light-based, unlike x-rays, no harmful radiations are emitted.

Lantis is currently in Phase 2 development of this system. Due to the significant upgrade in technology with Axsun’s laser engine, other components in its OCT Dental Imaging System need to be upgraded. As a result of this major system upgrade, full market introduction of the OCT System is now projected to be in the first quarter of 2009 as opposed to the original target date of the third quarter of 2008. Lantis will then apply for FDA 510k clearance in Phase 3 as the company finalizes the system specifications for the product. This clearance is typically obtained with a 90-day pre-market notification.

Once the company gains final approval from the FDA for the OCT Dental Imaging System, a large market opportunity awaits Lantis. It is estimated that the global market for these OCT systems is approximately 200,000 systems. At $20,000 to $25,000 per system the total potential market for Lantis’ OCT System is estimated to be from $4 billion to 5 billion. The management at Lantis is confident that the company will achieve at least $200 million in sales by the year 2011.

Let us hear your thoughts below:

Beacon Equity Research Featured Company: Lantis Laser, Inc. (LLSR.PK)

Friday, January 18th, 2008

Lantis Laser, Inc. (LLSR. PK) develops and commercializes advanced technologies for the dentistry industry. The Company has exclusive rights to the application of Optical Coherence Tomography (OCT) technology for dental diagnostic imaging through its license agreements with LightLab Imaging and Lawrence Livermore National Laboratory.

The “OCT Dental Imaging System”, a product of Lantis, is in its second phase. The System has an unprecedented high resolution of up to 10 times that of traditional dental x-rays. The new system is designed to provide early detection of tooth decay, periodontal disease and microstructural defects in teeth. These early detections allow dentists to promptly halt or even reverse the progress of the disease using minimally invasive procedures. Ultimately, the new system improves outcomes and enhances the quality of patient care.

Lantis’s OTC recently won the “2007 Best of What’s New” award in the Popular Science Magazine defeating thousands of entries to be one of the top 100 Editor’s picks. The OCT Dental Imaging System utilizes an innovative, safe, non-invasive light that is passed over the tooth surface using a pen-like handheld scanner to capture images of the teeth. It can be used safely on children (and pregnant women), enabling the dentist to diagnose and implement a program to safeguard the oral health of mother and child alike.

Let us hear your thoughts: Lantis Laser, Inc. Message Board

Beacon Equity Research Client: Lantis Laser Inc. (LLSR.PK) New Technology Receives Accolades

Friday, November 30th, 2007

Lantis Laser Inc., a New Jersey based company, was formed to commercialize the application of new dental industry technologies, having a competitive edge, exclusivity, and large market potential. Lantis is dedicated to developing advanced dental products for professionals to provide the highest standard of care to their patients.

The Company plans to launch its first product, the Optical Coherence Tomography (OCT) Dental Imaging System, in the third quarter of 2008. Lawrence Livermore National Laboratory and LightLab Imaging have given Lantis exclusive rights to the new technology until 2020. OCT represents a major advancement in dental imaging with the ability to provide minimally invasive, but still detailed images of the dental microstructures, allowing dentists to make an earlier and more accurate oral diagnosis.

Lantis’s OTC recently won the “2007 Best of What’s New” award in the Popular Science Magazine defeating thousands of entries to be one of the top 100 Editor’s picks. The technology won in the Personal Health Category as it provides up to 10 times the resolution of a standard x-ray with the exception of emitting the harmful radiation. The OCT Dental Imaging System utilizes an innovative, safe, non-invasive light that is passed over the tooth surface using a small, pen-like handheld scanner to capture images of the teeth. It can be used safely on children (and pregnant women), enabling the dentist to diagnose and implement a program to safeguard the oral health of mother and child alike.

Lantis President & CEO Stan Baron recently stated regarding the award, “We’re very pleased and honored to be recognized by the editors of Popular Science Magazine. Up to this point, the support and interest among dental professionals and the dental trade media have been extremely positive. However, Popular Science Magazine’s Best of What’s New award validates on a larger scale how the capture of reflected light can immediately and accurately reveal on a chair side monitor the earliest stages of cavities, gum disease, and microstructural deficiencies.”

Let us hear your thoughts below:

Lantis Laser Inc. (LLSR.PK) Awarded “Speculative Buy” Rating and $1.70 Price Target by Beacon Equity Research

Thursday, November 1st, 2007

Lantis Laser is focused on developing and commercializing advanced technologies for applications in the dentistry industry. The Company has exclusive rights to the application of Optical Coherence Tomography (OCT) technology for dental diagnostic imaging through its license agreements with LightLab Imaging and Lawrence Livermore National Laboratory.

The company is currently in Phase II development of its first product, the “OCT Dental Imaging System”. The System has an unparalleled resolution of up to 10 times greater than traditional dental x-rays and is designed to provide early detection of tooth decay, periodontal disease and microstructural defects in teeth. Early detection gives the dentist the advantage to quickly halt or reverse the progress of diseases using non or minimally invasive procedures, consequently improving outcomes and enhancing the quality of patient care.

In conclusion, Beacon Equity Research’s analyst stated, “The Company expects to place 360 OCT System units in 2008 and anticipates triple-digit revenue growth and sales exceeding $71 million in 2011. Management’s estimates assume a very conservative 5% penetration rate in the first four years of marketing the product. Taking into account LLSR’s technology advantage, exclusive licenses and the huge potential market, we are initiating coverage of Lantis Laser, Inc. with a Speculative Buy rating and a $1.70 price target.”

Let us hear your thoughts:

Lantis Laser (LLSR.PK) to Make Big Impact in Dental Equipment Market

Tuesday, July 17th, 2007

Most dentists still rely on the X-ray as their main purpose for detecting decay and other oral diseases. Lantis Laser (Pink Sheets: LLSR) has been working on dental imaging technology it can market to 140,000 dentists in 100,000 offices in the United States, which would expand the resolution current X-ray systems display.The current technology is insufficient because the resolution of the X-ray is not high enough for early detection of most oral diseases.

LLSR has created the Optical Coherence Tomography (OTC) Dental Imaging System in hopes of advancing technology so that dentists can treat the patient before the decay becomes worse. This could mean less trauma for the patient, lower cost, less time spent in the chair, and an overall higher standard of patient care.

Stan Baron, president and CEO of Lantis, said the company could have had a product out sooner, but needed to wait for the technology to grow so the product would become more cost-effective.

“Earlier OCT research systems were of a very high cost, and this did not meet Lantis’ price objectives that would allow almost every dentist to afford a system to use chair side,” Baron explained in a press release. “As technology has advanced, Lantis has been able to commercialize this cutting-edge technology by producing a cost effective OCT system, putting us in a position to achieve a greater market penetration.”

Last week, in a company press release, Lantis exposed five characteristics of the OCT that will make it ideal for dental imaging.

The first characteristic is the high resolution of the imaging system, which is expected to be 4 to 20 um compared with 50 microns for dental X-ray and 110 um for high frequency ultrasound.

Secondly is the tissue characterization. By using information inherent to the returning photon signals, OTC can perform both spectroscopic and polarization imaging to better characterize tissue and lesions.

Its small size is another positive factor of the OTC system. The fiber-based design allows for easy integration and easy access to all surfaces of the teeth and mouth. And this is done with a scanner about the size of a small pen.

The fourth characteristic has to do with the health of the patient. The light-based frequency of light is safe for biological tissue.

Finally, the company pointed out that the image captured chair-side will provide a display on a computer monitor that is real-time. This image can be stored in the patients file or transferred to another monitor digitally.